OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 72 filers reported holding OCULAR THERAPEUTIX INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $131,000 | +15.9% | 20,100 | +64.8% | 0.01% | +125.0% |
| Q1 2017 | $113,000 | -36.2% | 12,200 | -42.5% | 0.00% | -85.2% |
| Q4 2016 | $177,000 | +52.6% | 21,200 | +25.4% | 0.03% | -15.6% |
| Q3 2016 | $116,000 | +114.8% | 16,900 | +53.6% | 0.03% | -57.3% |
| Q2 2016 | $54,000 | -90.8% | 11,000 | -60.8% | 0.08% | -47.9% |
| Q2 2015 | $590,000 | +100.7% | 28,068 | +301.0% | 0.14% | +136.1% |
| Q1 2015 | $294,000 | – | 7,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
| Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
| DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
| Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
| SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
| Covestor Ltd | 37,404 | $117 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
| Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |